MicroRNA Biomarkers for Neonatal Opioid Withdrawal Syndrome

计划入组 50 人 · 首次发布于 2023 年 7 月 10 日

Methadone vs. Transdermal Fentanyl for Opioid Withdrawal Syndrome

计划入组 100 人 · 首次发布于 2023 年 1 月 26 日

CHF6563 in Babies With Neonatal Opioid Withdrawal Syndrome

计划入组 7 人 · 首次发布于 2019 年 9 月 26 日

opioid withdrawal symptom therapeutics

Lofexidine(Lucemyra)

C₁₁H₁₂Cl₂N₂O · Rx

opioid agonists (Molecumetics)

ALPORT SYNDROME FOUNDATION

United States

International Rett Syndrome Foundation

United States

RETT SYNDROME RESEARCH TRUST

United States

Lofexidine Trial Launched for Neonatal Opioid Withdrawal Syndrome

Symptom-Based Opioid Dosing Reduces Hospital Stay for Newborns with Withdrawal Syndrome

Spark Biomedical Completes Enrollment in Two Pivotal Neurostimulation Trials for Opioid Use Disorder and Neonatal Withdrawal